CompletedNCT00221429
Lithium or divalproex compared with placebo for acute mania in young people with bipolarity
About this title
Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
Read the official source — NCT00221429Medication studyAges 7–18United States
Understand this study
Who was this study for?
Listed age limits: 7 years to 18 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 153
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 7 Years to 18 Years
- Official registry ID
- NCT00221429
- Official title
Show the full official title
Pediatric Bipolar Collaborative Mood Stabilizer Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Children's Hospital Medical Center, Cincinnati, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including lithium and sodium divalproex.
Who was this study for?
Listed age limits: 7 years to 18 years.
